Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay

For the COVID-19 pandemic caused by SARS-CoV-2, there are currently no effective drugs or vaccines to treat this coronavirus infection. In this study, we focus on the main protease enzyme of SARS-CoV-2, 3CL(pro), which is critical for viral replication. We employ explicit solvent molecular dynamics...

Descripción completa

Detalles Bibliográficos
Autores principales: Loschwitz, Jennifer, Jäckering, Anna, Keutmann, Monika, Olagunju, Maryam, Eberle, Raphael J., Coronado, Monika Aparecida, Olubiyi, Olujide O., Strodel, Birgit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007184/
https://www.ncbi.nlm.nih.gov/pubmed/33862474
http://dx.doi.org/10.1016/j.bioorg.2021.104862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007184/
https://www.ncbi.nlm.nih.gov/pubmed/33862474
http://dx.doi.org/10.1016/j.bioorg.2021.104862

Ejemplares similares